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Promotion of electronic cigarettes: tobaccomarketing
reinvented?
Electronic cigarettes are not subject to the same marketing controls as tobacco products. Marisa
de Andrade, Gerard Hastings, and Kathryn Angus argue that their advertising is likely to appeal
to young people and undermine tobacco control policy
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The market in electronic cigarettes (e-cigarettes) has grown
rapidly over the past few years. Many small manufacturers have
emerged, and the tobacco industry has also taken an active
interest in the sector, buying up independent operators and
openly strategising about the business opportunities. Press
releases show that 121 product trademark applications were
made in the UK alone between May 2012 and June 2013.1
This growth has been accompanied by increased marketing.
The UK spend on e-cigarette promotion and related smoking
materials increased from £1.7m (€2m; $2.8m) in 2010 to £13.1m
in 2012. This increase is likely to continue as the tobacco
industry gets more involved. In 2013, a British American
Tobacco subsidiary spent £3.6m in just 2 months to promote
its Vype e-cigarette in the UK market and Lorillard, the US
tobacco multinational, which spent £19m promoting its
e-cigarette Blu in the United States, acquired the UK e-cigarette
brand Skycig.2 3
Concern has already been expressed about these developments.
The National Institute for Health and Care Excellence notes that
e-cigarettes “could, without regulation, be marketed in a way
that may ultimately promote smoking,”4 and researchers have
highlighted the need to monitor e-cigarette marketing.5-8 An
analysis of e-cigarette coverage in the UK and Scottish press
from 2007 to 2012 showed that newspaper stories often describe
the products as a way of getting around smoke-free legislation
and glamorise use through association with celebrities.9 We
were commissioned by Cancer Research UK to study e-cigarette
marketing and media coverage in the UK from May 2012 to
June 2013, during the period when theMedicines andHealthcare
Products Regulatory Authority was considering regulation of
the products as medicines. We searched for mentions of
e-cigarettes in the database Nexis UK, which holds the text
content of UK national and local newspapers, as well as in trade
press, tobacco journals, and television advertising (see web
appendix). We also analysed the use of five social networking
sites by seven leading e-cigarette brands over 40 days. Full
details of the methods and results have been published.1 Here
we use examples from the study to show how e-cigarettes are
being marketed to the general public and policy makers.
What is being marketed to consumers?
Marketing falls into two categories: consumer marketing aimed
at the general public and stakeholder marketing aimed at policy
makers and public health bodies. Consumer marketing is taking
many forms, including television commercials, sports and
cultural sponsorship, celebrity endorsement, social networking,
online advertising, point of sale displays, pricing strategies, and
product innovation. The line between editorial and paid
advertising is blurred by public relations activity. For example,
we found public opinion surveys commissioned by
manufacturers, overt lobbying asking consumers to “copy and
paste” correspondence to politicians that urged them to reject
regulation, and one brand sponsoring a university lecture on
e-cigarettes to “explain what they are, how they work, whether
they help people stop smoking and whether they are safe.”
Unsubstantiated or overstated claims
Safety and cessation are key marketing themes aimed at
smokers. E-cigarettes are described in newspaper articles and
advertisements as “a safer and much cheaper method to satisfy
a nicotine addiction,” a “healthier alternative,” and “harmless.”
They are also promoted as “an indispensable tool in the pathway
to quitting.” Although there is some evidence that e-cigarettes
are safer than conventional ones and can help with cessation,10 11
the Advertising Standards Authority judged that somemarketing
claims went beyond the available evidence.12 However, these
claims continued to appear in both advertising and editorial
after the rulings.
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Dual use
E-cigarette marketing is also promoting long term use as a
permanent alternative to tobacco, and a temporary one in public
places where smoking is banned. Thus adverts and editorials
promote “the freedom to enjoy the personal pleasures associated
with smoking in places where traditional smoking has been
banned.” One company emphasised this by registering its
e-cigarette under the trademark Lite-Up Anywhere, and another
promoted dual use, saying that its “smart plastic case [is]
designed to fit snuggly in the pocket, protect the e-cig, and even
house one regular tobacco cigarette for those adult smokers who
chose to dual between the two.”
Glamour, youth, and new users
Some e-cigarettes are being promoted as a lifestyle choice and
statement of identity (figure⇓). This advertising is backed by
stylish design and association with celebrity and fashionable
venues and events. E-cigarette companies are sponsoring
sporting events and using the resulting promotional opportunities
such as team kit advertising and free samples at events. Thus
Nicolites announced on Facebook that it is “happy and excited
to say we are now the principle [sic] partners for Birmingham
City Football Club.” Similarly, publicity around E-Lites’
sponsorship of the British Superbike Championship said that
its red and white branding was “reminiscent of the iconic
branding which was famously associated with motorsport
throughout the 1980s.” The company’s chief executive explained
to a retail trade magazine that he is “delighted to be . . .
partnering with a sport that was once synonymous with tobacco
sponsorship [as a] way of raising awareness that smoking has
been reinvented.”
Celebrity endorsement in the media—through paid-for
testimonials or having their name or image linked to a
product—is common (box), resulting in references to stars such
as Girls Aloud “puffing on e-cigarettes to cope with the stress
of their 10th anniversary tour.” Images of celebrity users and
product endorsements are then posted on social media platforms
and linked to brand websites and online feeds.
Independent e-cigarette companies and the tobacco industry are
promoting products as not only socially acceptable but socially
superior, and in the process developing an entirely “new
subculture.” Facebook pages for e-cigarette brands include
pictures of consumers posing with e-cigarettes with captions
such as “MAX-imum style” and articles on “10 ways to look
cooler while vaping an e-cigarette.” Vapestick has created a
retro-style computer game called Electronic Cigarette Wars.
Product innovation
Companies are offering e-cigarettes in various colours and
flavours and ones that are nicotine-free. Blu promoted an
innovative “smart pack” that alerts you to other users within 15
metres—both packs vibrate, flash, and transmit Facebook and
Twitter profiles—while Skycig introduced an “exclusive black
lightning design with electric yellow tip” for its nicotine-free
e-cigarette with the “active ingredient taurine,” which it claimed
“takes e-cigs to a whole new level.”
Smoking shisa pens is described in the Daily Mail and
Edinburgh Evening News as “one of the trendiest new activities
among the hip fashionable young crowd in the UK,” and “the
latest healthier alternative designed to replicate the sociable
custom [of smoking] minus the carcinogens and addictive
nicotine,” with “flavoured fumes [that] taste more like children’s
sweets than any sort of smoke substitute.” Online price discounts
are offered through social media—for example, a Facebook
page announces: “V-Shisha sunshine promo!! Save 20% . . . off
our 5-pack of 0% nicotine, fruity and sparkly disposables.”
What is beingmarketed at policymakers?
E-cigarettes, and the harm reduction approach they represent,
are providing a useful tool for targeting anti-smoking
stakeholders. As a tobacco industry spokesperson explains in a
tobacco industry trade journal: “business objectives and public
health objectives can be aligned for the best outcome . . . if all
involved recognise that harm reduction, as opposed to
prohibition, can become a meaningful part of an overall health
strategy designed to reduce tobacco related disease. Government
and industry can work together as partners.” Companies are
weaving public health pronouncements into marketing
campaigns. An e-cigarette Facebook page stated: “NICE
[National Institute for Health and Care Excellence] has become
the first public institution to recommend the electronic cigarette
for smokers who cannot quit”; another announced it was “proud
to say the charity Action Smoking and Health have supported
us in our partnership [the sponsorship of a football club].”
Nevertheless, companies generally worked to oppose the idea
of medical regulation. Two independent brands, for example,
organised petitions getting consumers to write to politicians to
persuade them to oppose EU legislation that would have put
controls on e-cigarettes.
A key outcome for e-cigarette companies and the tobacco
industry is legitimacy. In a trade article, a tobacco industry
analyst clarifies its benefits: “While cigarettes are being
progressively being [sic] locked away in cupboards and under
counters so that they cannot be seen by children, Tesco, the
UK’s leading retailer, has special stalls explicitly promoting a
brand of e-cigarette.” Similarly a company’s chief executive
explains that its e-cigarette acquisition “gives Lorillard a
meaningful seat at the table in the harm reduction debate, and
we intend to provide responsible leadership to this emerging
category.”
Public health implications
Large numbers of smokers switching from tobacco to safer
nicotine sources has the potential to bring substantial public
health gains. However, our audit shows that the commercial
exploitation of e-cigarettes is threatening this promise in three
ways.
Firstly, e-cigarettes are being promoted as lifestyle accessories
using a combination of evocative advertising, sponsorship, and
celebrity endorsement, all of which have an obvious appeal to
young people. This risks non-smokers being pulled into nicotine
use, a danger that is exacerbated by the development and
promotion of products for first time use. Furthermore, many of
these products replicate cigarettes so closely, both in appearance
and how they are consumed, that vaping looks just like—and
hence models—smoking. Even when the behaviour is
unequivocally vaping, it still models the idea of nicotine self
medication by inhaling a vapour into the lungs, along with the
implication that there is another more dangerous way of doing
this. This suggests the potential for e-cigarettes to inadvertently
promote smoking.
Secondly, the marketing of e-cigarettes risks undermining wider
tobacco control policies. The visual similarity between
conventional and electronic cigarettes, as well as between
smoking and vaping, means that e-cigarette advertising and
point of sale activity can be mistaken for (the now outlawed)
tobacco promotion. Similarly, the promotion of dual usage
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Celebrity endorsement of e-cigarettes
Characters on television programmes in the UK such as Eastenders and Lewis have used e-cigarettes, and the products are being promoted
through features in shows such as the Alan Titchmarsh Show.
Similarly in the US, Hollywood celebrities have shown how they use e-cigarettes to help them quit on television talk shows. Actress Katherine
Heigl, for example, used an e-cigarette while appearing on LiveWith David Letterman, claiming she was addicted to the product but it “wasn’t
bad for you,” and encouraged Letterman to have a “puff.”
Jonny Depp’s character uses an e-cigarette in the feature film The Tourist. Other Hollywood celebrities including Leonardo DiCaprio, Dennis
Quaid, and Kevin Connolly have also been photographed with e-cigarettes, and company websites feature pictures of A-list celebrities who
use their products.
undermines one of the key health benefits of smoke-free
legislation—the stimulus it gives smokers to quit.
Thirdly, the tobacco industry is moving into the e-cigarette
market and using e-cigarettes and harm reduction to build links
with public health, policy makers, and other stakeholders. This
process is accelerating: a wholly owned subsidiary of British
American Tobacco announced plans to license an alternative
nicotine delivery device with the Medicines and Healthcare
Products Regulatory Agency. This is jeopardising Article 5.3
of the Framework Convention on Tobacco Control, which
requires that development and implementation of public health
policy should be completely protected from industry influence.13
These problems demand a swift regulatory response. The
Medicines and Healthcare Products Regulatory Agency’s
decision in June to regulate e-cigarettes as medicines
acknowledges the need for controls, but these cannot wait for
the three years it has proposed. Specifically young people need
protection, marketing must to be tightly reined in, existing
tobacco control policy reinforced, and the tobacco industry
explicitly excluded from the policy making arena. One obvious
first step would be to regulate e-cigarettes as tobacco products.
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Figure
Examples of evocative images used in advertising of e-cigarettes in the UK and US
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2013;347:f7473 doi: 10.1136/bmj.f7473 (Published 22 December 2013) Page 4 of 4
ANALYSIS
